CA2288343A1 - Proteines secretees et polynucleotides les codant - Google Patents

Proteines secretees et polynucleotides les codant Download PDF

Info

Publication number
CA2288343A1
CA2288343A1 CA002288343A CA2288343A CA2288343A1 CA 2288343 A1 CA2288343 A1 CA 2288343A1 CA 002288343 A CA002288343 A CA 002288343A CA 2288343 A CA2288343 A CA 2288343A CA 2288343 A1 CA2288343 A1 CA 2288343A1
Authority
CA
Canada
Prior art keywords
amino acid
polynucleotide
seq
protein
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002288343A
Other languages
English (en)
Inventor
Kenneth Jacobs
John M. Mccoy
Edward R. Lavallie
Lisa A. Racie
David Merberg
Maurice Treacy
Vikki Spaulding
Michael J. Agostino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetics Institute LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2288343A1 publication Critical patent/CA2288343A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention porte sur des polynucléotides et sur les protéines codées par ceux-ci.
CA002288343A 1997-04-25 1998-04-24 Proteines secretees et polynucleotides les codant Abandoned CA2288343A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US84529697A 1997-04-25 1997-04-25
US08/845,296 1997-04-25
US6512598A 1998-04-23 1998-04-23
US09/065,125 1998-04-23
PCT/US1998/008336 WO1998049302A1 (fr) 1997-04-25 1998-04-24 Proteines secretees et polynucleotides les codant

Publications (1)

Publication Number Publication Date
CA2288343A1 true CA2288343A1 (fr) 1998-11-05

Family

ID=26745234

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002288343A Abandoned CA2288343A1 (fr) 1997-04-25 1998-04-24 Proteines secretees et polynucleotides les codant

Country Status (5)

Country Link
EP (1) EP0977853A1 (fr)
JP (1) JP2001527403A (fr)
AU (1) AU7159898A (fr)
CA (1) CA2288343A1 (fr)
WO (1) WO1998049302A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7473528B2 (en) * 1999-01-06 2009-01-06 Genenews Inc. Method for the detection of Chagas disease related gene transcripts in blood
US7083791B2 (en) 1999-03-25 2006-08-01 Genesis Research & Development Corporation Limited Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides
US6797271B2 (en) * 1999-03-25 2004-09-28 Genesis Research & Development Corporation Limited Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides
US6780987B1 (en) * 1999-12-10 2004-08-24 Trustees Of The Tufts College β-cap73 control of normal and abnormal cell migration
US6824973B2 (en) 2000-02-03 2004-11-30 Kirin Beer Kabushiki Kaisha Method of promoting stem cell proliferation or survival by contacting a cell with a stem cell factor-like polypeptide
AU5904101A (en) * 2000-04-05 2001-10-23 Hyseq Inc Methods and materials relating to novel stem cell growth factor-like polypeptides and polynucleotides
JP2007524566A (ja) 2002-12-20 2007-08-30 エンカム ファーマシューティカルズ アクティーゼルスカブ レセプターとリガンドの間の相互作用の調節の方法
PL2157192T3 (pl) 2003-10-10 2014-01-31 Deutsches Krebsforsch Kompozycje do diagnozowania i terapii chorób związanych z nieprawidłową ekspresją futrin (R-spondin)
EA018260B1 (ru) 2006-09-29 2013-06-28 Онкомед Фармасьютикалз, Инк. Антитела к дельта-подобному лиганду 4 человека и их применение
EP2997975A1 (fr) 2006-10-20 2016-03-23 Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts Réponse en tant que modulateurs de l'angiogenèse et la vasculogenèse
DK2173379T3 (en) 2007-07-02 2015-12-07 Oncomed Pharm Inc Compositions and methods for treatment and diagnosis of cancer
US8551479B2 (en) 2010-09-10 2013-10-08 Oncomed Pharmaceuticals, Inc. Methods for treating melanoma
BR112014000765A2 (pt) 2011-07-15 2017-06-13 Oncomed Pharm Inc agentes de ligação a rspo e seus usos
IN2015KN00350A (fr) 2012-07-13 2015-07-10 Oncomed Pharm Inc
JP2017528523A (ja) 2014-09-16 2017-09-28 オンコメッド ファーマシューティカルズ インコーポレイテッド 線維性疾患の治療

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO306996B1 (no) * 1989-02-17 2000-01-24 Bayer Ag Isolert bukspyttkjerteloey-celle-(ICA)-antigen for in vitro- bruk
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
US5707829A (en) * 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby

Also Published As

Publication number Publication date
AU7159898A (en) 1998-11-24
JP2001527403A (ja) 2001-12-25
WO1998049302A1 (fr) 1998-11-05
EP0977853A1 (fr) 2000-02-09

Similar Documents

Publication Publication Date Title
CA2278595A1 (fr) Proteines secretees et polynucleotides codant celles-ci
CA2285554A1 (fr) Proteines secretees et polynucleotides les codant
CA2283631A1 (fr) Proteines secretees et polynucleotides les codant
CA2288343A1 (fr) Proteines secretees et polynucleotides les codant
CA2283195A1 (fr) Proteines secretees et polynucleotides les codant
CA2274732A1 (fr) Proteines secretees et polynucleotides codant pour lesdites proteines
CA2306457A1 (fr) Proteines secretees et polynucleotides les codant
WO1998046757A2 (fr) Proteines secretees et polynucleotides codant ces proteines
CA2278770A1 (fr) Proteines secretees et polynucleotides les codant
CA2281059A1 (fr) Proteines secretees et polynucleotides les codant
WO1998044113A1 (fr) Proteines secretees et polynucleotides les codant
EP1012261A1 (fr) Proteines secretees et polynucleotides les codant
CA2283193A1 (fr) Proteines secretees et polynucleotides codant ces dernieres
CA2293363A1 (fr) Proteines secretees et polynucleotides les codant
CA2322732A1 (fr) Proteines secretees et polynucleotides les codant
CA2284109A1 (fr) Proteines secretees et polynucleotides les codant
CA2273845A1 (fr) Proteines secretees et polynucleotides les codant
CA2276085A1 (fr) Proteines secretees et polynucleotides les codant
EP0972026A2 (fr) Proteines secretees et polynucleotides codant ces proteines
EP1032594A1 (fr) Proteines secretees et polynucleotides les codant
CA2291485A1 (fr) Proteines secretees et polynucleotides codant ces proteines
EP1064302A1 (fr) Proteines secretees et polynucleotides les codant
WO1999009061A1 (fr) Proteines secretees
CA2285447A1 (fr) Proteines secretees et polynucleotides les codant
CA2291477A1 (fr) Semaphorine e d'origine humaine et polynucleotides codant cette semaphorine e

Legal Events

Date Code Title Description
FZDE Dead